13 High Growth International Stocks to Buy Right Now

Page 6 of 12

7. Ascendis Pharma A/S (NASDAQ:ASND)

5-Year Revenue Growth: 125.53%

Number of Hedge Fund Holders: 45

Ascendis Pharma A/S (NASDAQ:ASND) is one of the top high growth international stocks to buy right now. On September 8, Morgan Stanley analyst Maxwell Skor maintained a Buy rating on Ascendis Pharma A/S (NASDAQ:ASND) and set a price target of $250.00.

Ascendis Pharma A/S (NASDAQ:ASND) reported its fiscal Q2 2025 results on August 7, announcing €103.0 million in revenue for YORVIPATH and €50.7 million for SKYTROFA.

Jan Mikkelsen, Ascendis Pharma’s (NASDAQ:ASND) President and Chief Executive Officer, stated that the company is on the cusp of considerably transforming its financial profile and bringing its third high-value medicine to patients with the “robust global uptake of YORVIPATH and with TransCon CNP under U.S. FDA priority review.”

Headquartered in Hellerup, Denmark, Ascendis Pharma A/S (NASDAQ:ASND) is a biopharmaceutical company that develops drug candidates. It specializes in its TransCon technologies for the development of new therapies addressing unmet medical needs.

Page 6 of 12